Restructure Information

Purdue’s confirmed Plan of Reorganization (“Plan”) was vacated on appeal by the United States District Court for the Southern District of New York. Purdue is appealing the ruling while simultaneously continuing its efforts to forge yet further consensus around a Plan that will deliver billions of dollars to the American people for opioid abatement. The District Court decision does not affect Purdue’s operational stability or its ability to produce its many medications safely and effectively. We continue to operate fully, honoring our existing relationships and meeting our obligations to our partners, customers, and consumers. The company continues serving patients and consumers who rely on its medicines and products, pursuing its pipeline, and introducing medicines that will help save and improve lives.

RECENT NEWS

Harm Reduction Therapeutics to Receive Additional Funding for its Low-Cost Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma

Harm Reduction Therapeutics to Receive Additional Funding for its Low-Cost Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma $9 million in funding for commercial readiness…

FDA Grants Priority Review for Nalmefene Prefilled Syringe for the Treatment of Known or Suspected Opioid Overdos

Stamford, Conn., Jan, 18, 2023 – Purdue Pharma L.P. (“Purdue”) announced that FDA has accepted and granted priority review to the company’s Abbreviated New Drug Application (ANDA) for Nalmefene…

Prescription Drug Safety Network Reached More Than 22,000 Students with Prescription Drug Safety Digital Education During 2021-22 School Year

STAMFORD, Conn. – Nov. 2, 2022 – Purdue Pharma L.P. lauds the Prescription Drug Safety Network (“the Network”) for educating thousands of students about prescription drug safety during the 2021-2022…

Opinion – Steve Miller: Purdue Pharma chair on ‘tragic’ settlement decision; Stamford Advocate

December 31, 2021

The U.S. District Court’s decision vacating the settlement reached in Purdue’s bankruptcy proceedings threatens not only to upend U.S. bankruptcy law but also to significantly delay —and possibly prevent entirely — billions of dollars from being used to address the opioid crisis. It is a regrettable and tragic outcome that could have been, and hopefully still can be, avoided.

featured-image_OSU-01

Nikki’s House: Supporting Women in Recovery

In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart failure. When she inherited his home in Warren, Ohio, Nicole knew she could do something special with it. Five months later, Nikki’s House – a recovery home for women healing from substance use disorder – opened its doors to the first two women. Five years later, Nikki’s House has given approximately 250 women the opportunity to live sober lives.

featured-image_Roby-01

Move Together, Heal Together

Ethan Hershman has been in recovery from substance use disorder for 28 years. While he’s never once relapsed, he’s seen his fair share of people who haven’t been as fortunate and, in many tragic cases, have lost their lives. He finally asked himself, “why?”

featured-image_ORII-hands-01

Renewal House: Keeping Families Together and Creating Bright Futures for Women and Children

Mothers seeking treatment for substance use disorder often must choose between taking care of their children and taking care of themselves. Renewal House is offering mothers in Middle Tennessee a different option – one where they don’t have to choose.

Privacy Policy Updates

Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.